About me
Kevin Eisenfrats co-founded Contraline and has been CEO since its inception. Contraline is a biotechnology company developing paradigm-shifting innovations in reproductive health, starting with the world's first long-lasting, reversible male contraceptive. Kevin has led Contraline from an idea to clinical-stage company, built a world-class team, and has brought in >$30M in funding.